Studies were selected if they were double blind RCTs that compared celecoxib at a licensed therapeutic dose for ≥12 weeks with placebo or another NSAID in patients with active RA or OA. 1 reviewer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback